| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Clarus Therapeutics Holdings Inc (NASDAQ: CRXT)
CRXT Technical Analysis
5
| As on 8th Nov 2022 CRXT STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.31 & Strong Sell for SHORT-TERM with Stoploss of 5.41 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRXTSTOCK Price
| Open | 0.03 | Change | Price | % |
| High | 0.03 | 1 Day | -0.01 | -33.33 |
| Low | 0.02 | 1 Week | 0.00 | 0.00 |
| Close | 0.02 | 1 Month | -0.01 | -33.33 |
| Volume | 84737 | 1 Year | -8.02 | -99.75 |
| 52 Week High 9.63 | 52 Week Low 0.02 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 146.67 | 0.53% |
| AKTS | 0.10 | 11.11% |
| WORX | 2.12 | 116.33% |
| QUBT | 4.76 | 29.35% |
| LMDX | 0.02 | 0.00% |
| SMCI | 29.70 | 5.06% |
| MSTR | 397.28 | -16.16% |
| MARA | 23.81 | 22.17% |
| CRNC | 5.83 | 106.74% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRXT Daily Charts |
CRXT Intraday Charts |
Whats New @ Bazaartrend |
CRXT Free Analysis |
|
|
CRXT Important Levels Intraday
| RESISTANCE | 0.04 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| SUPPORT | 0.01 |
| SUPPORT | 0.01 |
| SUPPORT | 0.01 |
| SUPPORT | 0.00 |
CRXT Forecast November 2024
| 4th UP Forecast | 8.83 |
| 3rd UP Forecast | 6 |
| 2nd UP Forecast | 4.26 |
| 1st UP Forecast | 2.51 |
| 1st DOWN Forecast | -2.47 |
| 2nd DOWN Forecast | -4.22 |
| 3rd DOWN Forecast | -5.96 |
| 4th DOWN Forecast | -8.79 |
CRXT Weekly Forecast
| 4th UP Forecast | 5.72 |
| 3rd UP Forecast | 3.89 |
| 2nd UP Forecast | 2.76 |
| 1st UP Forecast | 1.63 |
| 1st DOWN Forecast | -1.59 |
| 2nd DOWN Forecast | -2.72 |
| 3rd DOWN Forecast | -3.85 |
| 4th DOWN Forecast | -5.68 |
CRXT Forecast2024
| 4th UP Forecast | 20.35 |
| 3rd UP Forecast | 13.83 |
| 2nd UP Forecast | 9.8 |
| 1st UP Forecast | 5.77 |
| 1st DOWN Forecast | -5.73 |
| 2nd DOWN Forecast | -9.76 |
| 3rd DOWN Forecast | -13.79 |
| 4th DOWN Forecast | -20.31 |
Clarus Therapeutics Holdings Inc ( NASDAQ USA Symbol : CRXT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRXT Business Profile
Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service